financetom
Business
financetom
/
Business
/
Market Chatter: Goldman Sachs Partner David Kamo Leaves for Evercore
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Goldman Sachs Partner David Kamo Leaves for Evercore
Aug 9, 2024 12:26 PM

03:14 PM EDT, 08/09/2024 (MT Newswires) -- Goldman Sachs Group ( GS ) partner and global co-head of financial-sponsor mergers and acquisitions, David Kamo, left to join Evercore ( EVR ) as a senior managing director, Bloomberg reported Friday, citing people with the knowledge of the matter.

Goldman and Evercore ( EVR ) declined to comment, Bloomberg said.

The companies didn't immediately respond to requests for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 489.38, Change: +3.61, Percent Change: +0.74

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sun Life Announces Leadership Changes for Sun Life Canada
Sun Life Announces Leadership Changes for Sun Life Canada
Sep 11, 2024
08:21 AM EDT, 09/11/2024 (MT Newswires) -- Sun Life (SLF.TO, SLF) on Wednesday said Jacques Goulet has been named executive chair of Sun Life Canada while Jessica Tan succeeds him as president of Sun Life Canada. The two will assume their new positions on September 30. Goulet, who joined Sun Life in 2018, will also continue as the chair of...
Eupraxia Pharmaceuticals Reports Positive Data from RESOLVE Trial
Eupraxia Pharmaceuticals Reports Positive Data from RESOLVE Trial
Sep 11, 2024
08:15 AM EDT, 09/11/2024 (MT Newswires) -- Eupraxia Pharmaceuticals ( EPRX ) on Wednesday announced additional positive clinical data from its RESOLVE Phase 1b/2a trial, which is evaluating the safety and efficacy of EP-104GI as a treatment for eosinophilic esophagitis (EoE), an allergic condition that causes the esophagus to be inflamed and not contract properly. The results from the fourth...
BriaCell Reports Positive Data for Bria-IMT in Phase 2 Metastatic Breast Cancer Study - Shares Soar Premarket
BriaCell Reports Positive Data for Bria-IMT in Phase 2 Metastatic Breast Cancer Study - Shares Soar Premarket
Sep 11, 2024
08:19 AM EDT, 09/11/2024 (MT Newswires) -- BriaCell Therapeutics ( BCTX ) said Wednesday it yielded positive overall survival data in a phase 2 late-stage metastatic breast cancer study evaluating Bria-IMT in combination with an immune check point inhibitor. The 54-patient study showed median survival of 15.6 months in patients treated with Bria-MT compared with 6.7 to 9.3 months for...
Poet Technologies Combines Optical Engine With InSiGa's EML Driver
Poet Technologies Combines Optical Engine With InSiGa's EML Driver
Sep 11, 2024
08:15 AM EDT, 09/11/2024 (MT Newswires) -- Poet Technologies ( POET ) and Chengdu InSiGa Semiconductor Technologies said Wednesday they have developed a solution for 200Gx4 applications using Poet's 200Gx4 transmit optical engine and InSiGa's 200G/lane EML driver ISG-D9616 for 800G and 1.6T modules. The companies will showcase the new product at the China International Optoelectronic Expo until Friday, Poet...
Copyright 2023-2025 - www.financetom.com All Rights Reserved